Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma

CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation

(2016) Yeo-Jung Kwon et al.   PLoS One

Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review

(2015) Francesca De Iuliis et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Association between CYP1B1 Gene Polymorphisms and Risk Factors and Susceptibility to Laryngeal Cancer

(2015) Ze-Qing Li   MEDICAL SCIENCE MONITOR

Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial

(2014) V Le Morvan et al.   PHARMACOGENOMICS JOURNAL

Gene Expression Correlations in Human Cancer Cell Lines Define Molecular Interaction Networks for Epithelial Phenotype

(2014) Kurt W. Kohn et al.   PLoS One

NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses

(2014) William C. Reinhold et al.   PLoS One

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

(2012) Jordi Barretina et al.   NATURE

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

(2012) Cole Trapnell et al.   Nature Protocols

Role of CYP1B1 Gene Polymorphisms in Bladder Cancer Susceptibility

(2011) Antonio S. Salinas-Sánchez et al.   JOURNAL OF UROLOGY

Structural Characterization of the Complex between α-Naphthoflavone and Human Cytochrome P450 1B1

(2010) An Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: Evidence from 6501 subjects

(2010) Bo Chen et al.   LUNG CANCER

Cytochrome P450 1B1 Gene Polymorphisms as Predictors of Anticancer Drug Activity: Studies with In vitro Models

(2010) A. Laroche-Clary et al.   MOLECULAR CANCER THERAPEUTICS

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays

(2009) Yifang Hu et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Genetic Variants Contributing to Daunorubicin-Induced Cytotoxicity

(2008) R. S. Huang et al.   CANCER RESEARCH

CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians

(2008) J. Beuten et al.   CARCINOGENESIS

Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel

(2008) T. M. Sissung et al.   MOLECULAR CANCER THERAPEUTICS